Craneware Share Discussion Threads

[wjccghcc] 08/9/2015 09:03

Their revenue recognition policy means that sales growth doesn't reflect the underlying progress of the business. 113% renewals by $ value and long-term contracts means they'll be churning out 10% earnings growth for the foreseeable future.

[opodio] 08/9/2015 07:23

interesting

[elcapital] 01/7/2015 19:58

This looks a bit toppy. Worth looking at a bit deeper I think.

[newtothisgame3] 14/1/2015 10:50

Craneware (CRW) December Bear Trap Could Lead Back To 580p Zone - LSE:CRW News
Today, 10:17 AM
Perhaps what is most interesting about covering small caps on a daily basis is the way that in terms of recovery plays similar configurations crop up again - CRW

[cnx] 16/9/2014 13:19

from the Chairmans's statement of 16 September 2014



"Chairman's Statement

I am pleased to report that following a promising first half, the increased sales activity which had been building over prior years has resulted in a record sales performance for the Group during the year. The marketplace for our products is developing as we had anticipated, with sales now coming from both individual hospitals and larger hospital groups. This trend has continued in the first months of the new fiscal year and we expect this to continue in a positive manner in the year ahead. The strength of our business model, which spreads the value of each contract over its lifetime, is such that these sales successes are building a solid platform of future revenue on which the business will grow.

The total value of contracts signed in the year increased by 84% to $71.0m (FY13: $38.5m). In accordance with the Group's revenue recognition policy, the vast majority of the revenue from these sales will benefit future years. Revenues increased to $42.6m, adjusted EBITDA increased to $13.1m and adjusted EPS increased to 34.0 cents. The Group continued to benefit from strong operational cash flow, closing the period with a cash balance of $32.6m (30 June 2013: $30.3m).

We are now benefiting from the restructuring of the business in previous periods, achieving record sales and ensuring scalability and sustainability for the future. We continue to invest in our products and people to ensure that we remain at the forefront of this evolving sector of the US healthcare IT market, the world's largest IT industry. With the acquisition of Kestros Limited, an emerging technology player in the patient access market, after the year end, the Group is well positioned to develop solutions to address the ongoing consumerisation trend within healthcare on both sides of the Atlantic.

The market environment for the business remains positive. Craneware's growing product set addresses many of the problems facing US healthcare organisations and the Group is increasing in strategic importance to its customer base. I am pleased to report that we recruited Colleen Blye and Russ Rudish to the Board in November 2013 and August 2014 respectively. Colleen and Russ will be able to provide significant additional insight into the challenges facing US healthcare organisations.

With a quarter of US hospitals as customers, high levels of visibility over future revenue, a significantly strengthened operating structure and enhanced product set, we are confident in the ongoing success of the Group. "

[cnx] 18/3/2014 22:47

Interim Results

11 March 2014 - Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, announces its unaudited results for the six months ended 31 December 2013.

Financial Highlights (US dollars)
-- Revenue increased 5% to $21.1m (H1 2013: $20.1m)
-- Adjusted EBITDA(1) increased 6% to $5.7m (H1 2013: $5.4m)
-- Profit before tax increased 7% to $4.8m (H1 2013: $4.5m)
-- Adjusted basic EPS increased 8% to 14.3 cents per share (H1 2013: 13.2 cents per share)
-- Cash at period end $30.6m (H1 2013: $28.6m and $30.3m at 30 June 2013)
-- Proposed interim dividend of 5.7p per share (H1 2013: 5.2p per share)

(1.) Adjusted EBITDA refers to earnings before interest, tax, depreciation, amortisation, share based payments, released deferred consideration and transaction related costs

Operational Highlights

-- Good sales performance driven by incremental increases in the number of deals, in the size of hospital groups, the overall deal size and the number of longer-term contracts
-- 2013 Best in KLAS Awards: Chargemaster Toolkit and Bill Analyzer
-- Good growth in InSight Audit supporting the 'Gateway Products' strategy

-- Supportive market environment - The Affordable Care Act, new billing models, healthcare consumerisation, RAC and third party payor audits, market consolidation and affiliations
-- Strong revenue visibility over the remainder of the year and beyond

Keith Neilson, CEO of Craneware commented:

"Craneware remains at the forefront of providing solutions to US healthcare providers so they can achieve the revenue integrity required to support improved patient care and outcomes. We have seen a continued increase in sales during the period, to progressively larger hospital groups. The US Healthcare market seems to be settling as strategies are developing to support the need for change and deal with the uncertainties of the Affordable Care Act. With a strong product suite, clear strategic direction and high levels of revenue visibility, we are confident of continued future growth."

[phoenix1234] 13/11/2013 07:46

sensible comment here

www.shareprophets.advfn.com/views/2620/craneware-plc-agm-trading-update-does-recent-deal-read-across-suggest-value

[supernumerary] 09/8/2013 15:13

That's what I've been wondering - it certainly looks like a leak of some sort. It's already getting to the stage where the company will have to make a statement.

[wjccghcc] 09/8/2013 13:46

Given their slightly chequered history with the stock market, the multiple vs US comparables and the 100% US nature of their business, it wouldn't surprise me if they were bought out.

[supernumerary] 08/8/2013 20:12

What's brought this back to life?

[mortimer7] 27/2/2013 14:36

Good set of results without any share price reaction, and now a big Director buy.
CEO bought 12.8k at 3.95p :- bodes well

[cambium] 24/2/2013 21:58

Results 26th Tuesday should make for interesting reading

[cambium] 05/2/2013 14:12

IMS due on the 22nd. These could push ahead with some good news.

[cerrito] 27/1/2013 23:33

Just been looking at these after last Monday's trading statement caught my eye
Alot to like about this company; exposure to the US$ which no doubt will strengthen against the £; a good diversification from anything else that I own; a good balance sheet structure and cash flow figures; diversified shareholder base with management having a good stake.
I see that currently trades at an historic 18.4x-fair enough if there is very good growth; there will be growth but not sure if enough to justify this pe; as a for example I note in the annual results for the year ending June 12 visible revenue for the three years from June 12 was $108m-not all that much of an increase from the $101m in June 2011.

[lucky_punter] 09/11/2012 08:13

Software specialist Craneware's (LON:CRW) shares spiked 7% in early deals ahead of what is likely to be an upbeat statement from the company's chief executive at the annual meeting.

[cambium] 08/11/2012 18:33

What happened at the close. Lets see what the morning.